Pharmanutra S.p.A.

Milan Stock Exchange PHN.MI

Pharmanutra S.p.A. Debt to Equity Ratio for the year ending December 31, 2023: 0.51

Pharmanutra S.p.A. Debt to Equity Ratio is 0.51 for the year ending December 31, 2023, a 48.00% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Pharmanutra S.p.A. Debt to Equity Ratio for the year ending December 31, 2022 was 0.35, a 147.16% change year over year.
  • Pharmanutra S.p.A. Debt to Equity Ratio for the year ending December 31, 2021 was 0.14, a 220.14% change year over year.
  • Pharmanutra S.p.A. Debt to Equity Ratio for the year ending December 31, 2020 was 0.04, a -80.68% change year over year.
  • Pharmanutra S.p.A. Debt to Equity Ratio for the year ending December 31, 2019 was 0.23, a 4.11% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO Mr. Andrea Lacorte
IPO Date July 18, 2017
Location Italy
Headquarters Via delle Lenze 216/B
Employees 112
Sector Healthcare
Industries
Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Similar companies

ELN.MI

EL.En. S.p.A.

USD 11.03

-2.25%

TNXT.MI

Tinexta S.p.A.

USD 8.23

-1.83%

DGV.MI

Digital Value S.p.A.

USD 21.51

0.36%

SES.MI

SeSa S.p.A.

USD 70.41

-0.60%

WIIT.MI

Wiit S.p.A.

USD 18.65

-2.12%

StockViz Staff

February 6, 2025

Any question? Send us an email